B
Chemed Corporation
CHE
$564.34
-$1.18-0.21%
B
Buy
5/2/2024Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 5/2/2024 due to a substantial decline in the growth index, total return index and efficiency index. EBIT declined 36.36% from $113.66M to $72.33M, earnings per share declined from $5.9002 to $4.24, and net income declined 27.8% from $90.05M to $65.02M.
Chemed Corporation (CHE) was downgraded to B- from B on 5/2/2024 due to a substantial decline in the growth index, total return index and efficiency index. EBIT declined 36.36% from $113.66M to $72.33M, earnings per share declined from $5.9002 to $4.24, and net income declined 27.8% from $90.05M to $65.02M.
B
Buy
3/1/2024Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 3/1/2024 due to a large increase in the growth index, volatility index and valuation index. Operating cash flow increased 275.3% from $28.93M to $108.56M, EBIT increased 30.86% from $86.85M to $113.66M, and earnings per share increased from $4.93 to $5.9002.
Chemed Corporation (CHE) was upgraded to B from B- on 3/1/2024 due to a large increase in the growth index, volatility index and valuation index. Operating cash flow increased 275.3% from $28.93M to $108.56M, EBIT increased 30.86% from $86.85M to $113.66M, and earnings per share increased from $4.93 to $5.9002.
B
Buy
12/22/2023Upgraded
Chemed Corporation (CHE) was upgraded to B- from C+ on 12/22/2023 due to a noticeable increase in the volatility index and total return index.
Chemed Corporation (CHE) was upgraded to B- from C+ on 12/22/2023 due to a noticeable increase in the volatility index and total return index.
C
Hold
10/30/2023Upgraded
Chemed Corporation (CHE) was upgraded to C+ from C on 10/30/2023 due to an increase in the growth index, valuation index and solvency index. Earnings per share increased from $3.51 to $4.93, EBIT increased 24.95% from $69.51M to $86.85M, and the quick ratio increased from 0.93 to 1.15.
Chemed Corporation (CHE) was upgraded to C+ from C on 10/30/2023 due to an increase in the growth index, valuation index and solvency index. Earnings per share increased from $3.51 to $4.93, EBIT increased 24.95% from $69.51M to $86.85M, and the quick ratio increased from 0.93 to 1.15.
C
Hold
10/3/2023Downgrade
Chemed Corporation (CHE) was downgraded to C from C+ on 10/3/2023 due to a large decline in the volatility index and total return index.
Chemed Corporation (CHE) was downgraded to C from C+ on 10/3/2023 due to a large decline in the volatility index and total return index.
C
Hold
8/1/2023Downgrade
Chemed Corporation (CHE) was downgraded to C+ from B- on 8/1/2023 due to a decline in the valuation index, growth index and volatility index. EBIT declined 4.55% from $72.82M to $69.51M, earnings per share declined from $3.58 to $3.51, and total revenue declined 1.13% from $560.16M to $553.82M.
Chemed Corporation (CHE) was downgraded to C+ from B- on 8/1/2023 due to a decline in the valuation index, growth index and volatility index. EBIT declined 4.55% from $72.82M to $69.51M, earnings per share declined from $3.58 to $3.51, and total revenue declined 1.13% from $560.16M to $553.82M.
B
Buy
5/1/2023Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 5/1/2023 due to a significant decline in the growth index and valuation index. Operating cash flow declined 39.63% from $100.2M to $60.49M, EBIT declined 14.35% from $85.02M to $72.82M, and earnings per share declined from $4.1205 to $3.58.
Chemed Corporation (CHE) was downgraded to B- from B on 5/1/2023 due to a significant decline in the growth index and valuation index. Operating cash flow declined 39.63% from $100.2M to $60.49M, EBIT declined 14.35% from $85.02M to $72.82M, and earnings per share declined from $4.1205 to $3.58.
B
Buy
2/28/2023Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 2/28/2023 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 92.63% from $52.02M to $100.2M, the quick ratio increased from 0.43 to 0.72, and debt to equity declined from 0.19 to 0.17.
Chemed Corporation (CHE) was upgraded to B from B- on 2/28/2023 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 92.63% from $52.02M to $100.2M, the quick ratio increased from 0.43 to 0.72, and debt to equity declined from 0.19 to 0.17.
B
Buy
12/20/2022Upgraded
Chemed Corporation (CHE) was upgraded to B- from C+ on 12/20/2022 due to an increase in the total return index and volatility index.
Chemed Corporation (CHE) was upgraded to B- from C+ on 12/20/2022 due to an increase in the total return index and volatility index.
C
Hold
11/21/2022Upgraded
Chemed Corporation (CHE) was upgraded to C+ from C on 11/21/2022 due to an increase in the volatility index.
Chemed Corporation (CHE) was upgraded to C+ from C on 11/21/2022 due to an increase in the volatility index.
C
Hold
11/4/2022Downgrade
Chemed Corporation (CHE) was downgraded to C from C+ on 11/4/2022 due to a large decline in the growth index, valuation index and volatility index. Earnings per share declined from $4.4 to $3.78, EBIT declined 12.05% from $91.94M to $80.86M, and operating cash flow declined 8.06% from $56.58M to $52.02M.
Chemed Corporation (CHE) was downgraded to C from C+ on 11/4/2022 due to a large decline in the growth index, valuation index and volatility index. Earnings per share declined from $4.4 to $3.78, EBIT declined 12.05% from $91.94M to $80.86M, and operating cash flow declined 8.06% from $56.58M to $52.02M.
C
Hold
9/30/2022Downgrade
Chemed Corporation (CHE) was downgraded to C+ from B- on 9/30/2022 due to a noticeable decline in the volatility index and total return index.
Chemed Corporation (CHE) was downgraded to C+ from B- on 9/30/2022 due to a noticeable decline in the volatility index and total return index.
B
Buy
9/12/2022Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 9/12/2022 due to a decline in the total return index and volatility index.
Chemed Corporation (CHE) was downgraded to B- from B on 9/12/2022 due to a decline in the total return index and volatility index.
B
Buy
7/1/2022Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 7/1/2022 due to an increase in the volatility index.
Chemed Corporation (CHE) was upgraded to B from B- on 7/1/2022 due to an increase in the volatility index.
B
Buy
6/16/2022Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 6/16/2022 due to a noticeable decline in the volatility index.
Chemed Corporation (CHE) was downgraded to B- from B on 6/16/2022 due to a noticeable decline in the volatility index.
B
Buy
5/12/2022Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 5/12/2022 due to a noticeable increase in the total return index and growth index. Operating cash flow increased 59.02% from $63.57M to $101.09M.
Chemed Corporation (CHE) was upgraded to B from B- on 5/12/2022 due to a noticeable increase in the total return index and growth index. Operating cash flow increased 59.02% from $63.57M to $101.09M.
B
Buy
3/15/2022Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 3/15/2022 due to a significant decline in the growth index, valuation index and solvency index. Debt to equity increased from 0.05 to 0.36, and operating cash flow declined 43.74% from $112.99M to $63.57M.
Chemed Corporation (CHE) was downgraded to B- from B on 3/15/2022 due to a significant decline in the growth index, valuation index and solvency index. Debt to equity increased from 0.05 to 0.36, and operating cash flow declined 43.74% from $112.99M to $63.57M.
B
Buy
2/18/2022Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 2/18/2022 due to an increase in the total return index and volatility index.
Chemed Corporation (CHE) was upgraded to B from B- on 2/18/2022 due to an increase in the total return index and volatility index.
B
Buy
2/3/2022Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 2/3/2022 due to a decline in the total return index.
Chemed Corporation (CHE) was downgraded to B- from B on 2/3/2022 due to a decline in the total return index.
B
Buy
12/20/2021Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 12/20/2021 due to an increase in the volatility index and total return index.
Chemed Corporation (CHE) was upgraded to B from B- on 12/20/2021 due to an increase in the volatility index and total return index.
B
Buy
11/3/2021Upgraded
Chemed Corporation (CHE) was upgraded to B- from C+ on 11/3/2021 due to a large increase in the growth index and total return index. Operating cash flow increased 346.24% from $25.32M to $112.99M, earnings per share increased from $3.51 to $4.55, and EBIT increased 29.43% from $71.8M to $92.93M.
Chemed Corporation (CHE) was upgraded to B- from C+ on 11/3/2021 due to a large increase in the growth index and total return index. Operating cash flow increased 346.24% from $25.32M to $112.99M, earnings per share increased from $3.51 to $4.55, and EBIT increased 29.43% from $71.8M to $92.93M.
C
Hold
10/15/2021Downgrade
Chemed Corporation (CHE) was downgraded to C+ from B- on 10/15/2021 due to a decline in the total return index and volatility index.
Chemed Corporation (CHE) was downgraded to C+ from B- on 10/15/2021 due to a decline in the total return index and volatility index.
B
Buy
8/12/2021Downgrade
Chemed Corporation (CHE) was downgraded to B- from B on 8/12/2021 due to a significant decline in the total return index, volatility index and growth index. Operating cash flow declined 76.27% from $106.72M to $25.32M, earnings per share declined from $4.01 to $3.51, and EBIT declined 10.74% from $80.44M to $71.8M.
Chemed Corporation (CHE) was downgraded to B- from B on 8/12/2021 due to a significant decline in the total return index, volatility index and growth index. Operating cash flow declined 76.27% from $106.72M to $25.32M, earnings per share declined from $4.01 to $3.51, and EBIT declined 10.74% from $80.44M to $71.8M.
B
Buy
12/10/2019Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 12/10/2019 due to a decline in the total return index and valuation index.
Chemed Corporation (CHE) was downgraded to B from B+ on 12/10/2019 due to a decline in the total return index and valuation index.
B
Buy
11/25/2019Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 11/25/2019 due to an increase in the total return index and volatility index.
Chemed Corporation (CHE) was upgraded to B+ from B on 11/25/2019 due to an increase in the total return index and volatility index.
B
Buy
11/7/2019Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 11/7/2019 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.19 to 0.24, and the quick ratio declined from 0.62 to 0.49.
Chemed Corporation (CHE) was downgraded to B from B+ on 11/7/2019 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.19 to 0.24, and the quick ratio declined from 0.62 to 0.49.
B
Buy
10/23/2019Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 10/23/2019 due to a noticeable increase in the total return index and volatility index.
Chemed Corporation (CHE) was upgraded to B+ from B on 10/23/2019 due to a noticeable increase in the total return index and volatility index.
B
Buy
8/2/2019Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 8/2/2019 due to a decline in the valuation index.
Chemed Corporation (CHE) was downgraded to B from B+ on 8/2/2019 due to a decline in the valuation index.
B
Buy
7/29/2019Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 7/29/2019 due to an increase in the total return index and volatility index.
Chemed Corporation (CHE) was upgraded to B+ from B on 7/29/2019 due to an increase in the total return index and volatility index.
B
Buy
7/12/2019Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 7/12/2019 due to a decline in the growth index, valuation index and total return index. EBIT declined 18.61% from $68.59M to $55.83M, and earnings per share declined from $3.2614 to $2.7.
Chemed Corporation (CHE) was downgraded to B from B+ on 7/12/2019 due to a decline in the growth index, valuation index and total return index. EBIT declined 18.61% from $68.59M to $55.83M, and earnings per share declined from $3.2614 to $2.7.
B
Buy
4/15/2019Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 4/15/2019 due to a noticeable increase in the total return index, solvency index and valuation index. Debt to equity declined from 0.23 to 0.15.
Chemed Corporation (CHE) was upgraded to B+ from B on 4/15/2019 due to a noticeable increase in the total return index, solvency index and valuation index. Debt to equity declined from 0.23 to 0.15.
B
Buy
10/18/2018Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 10/18/2018 due to a decline in the total return index and volatility index.
Chemed Corporation (CHE) was downgraded to B from B+ on 10/18/2018 due to a decline in the total return index and volatility index.
B
Buy
10/3/2018Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 10/3/2018 due to an increase in the volatility index.
Chemed Corporation (CHE) was upgraded to B+ from B on 10/3/2018 due to an increase in the volatility index.
B
Buy
9/13/2018Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 9/13/2018 due to a noticeable decline in the total return index.
Chemed Corporation (CHE) was downgraded to B from B+ on 9/13/2018 due to a noticeable decline in the total return index.
B
Buy
9/7/2018Downgrade
Chemed Corporation (CHE) was downgraded to B+ from A- on 9/7/2018 due to a noticeable decline in the total return index and valuation index.
Chemed Corporation (CHE) was downgraded to B+ from A- on 9/7/2018 due to a noticeable decline in the total return index and valuation index.
A
Buy
8/20/2018Downgrade
Chemed Corporation (CHE) was downgraded to A- from A on 8/20/2018 due to a decline in the total return index.
Chemed Corporation (CHE) was downgraded to A- from A on 8/20/2018 due to a decline in the total return index.
A
Buy
8/1/2018Upgraded
Chemed Corporation (CHE) was upgraded to A from B on 8/1/2018 due to a major increase in the valuation index, growth index and solvency index. Debt to equity declined from 0.28 to 0.19, earnings per share increased from $2.66 to $3.27, and the quick ratio increased from 0.71 to 0.79.
Chemed Corporation (CHE) was upgraded to A from B on 8/1/2018 due to a major increase in the valuation index, growth index and solvency index. Debt to equity declined from 0.28 to 0.19, earnings per share increased from $2.66 to $3.27, and the quick ratio increased from 0.71 to 0.79.
B
Buy
3/2/2018Upgraded
Chemed Corporation (CHE) was upgraded to B from B- on 3/2/2018 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from $2.13 to $3.2501, EBIT increased 3.17% from $54.56M to $56.29M, and total revenue increased 2.61% from $417.44M to $428.36M.
Chemed Corporation (CHE) was upgraded to B from B- on 3/2/2018 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from $2.13 to $3.2501, EBIT increased 3.17% from $54.56M to $56.29M, and total revenue increased 2.61% from $417.44M to $428.36M.
B
Buy
10/27/2017Upgraded
Chemed Corporation (CHE) was upgraded to B- from C on 10/27/2017 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from -$1.3527 to $2.13, operating cash flow increased 187.48% from $31.54M to $90.67M, and debt to equity declined from 0.28 to 0.17.
Chemed Corporation (CHE) was upgraded to B- from C on 10/27/2017 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from -$1.3527 to $2.13, operating cash flow increased 187.48% from $31.54M to $90.67M, and debt to equity declined from 0.28 to 0.17.
C
Hold
10/20/2017Downgrade
Chemed Corporation (CHE) was downgraded to C from C+ on 10/20/2017 due to a noticeable decline in the total return index and valuation index.
Chemed Corporation (CHE) was downgraded to C from C+ on 10/20/2017 due to a noticeable decline in the total return index and valuation index.
C
Hold
10/5/2017Upgraded
Chemed Corporation (CHE) was upgraded to C+ from C on 10/5/2017 due to an increase in the volatility index.
Chemed Corporation (CHE) was upgraded to C+ from C on 10/5/2017 due to an increase in the volatility index.
C
Hold
8/23/2017Downgrade
Chemed Corporation (CHE) was downgraded to C from C+ on 8/23/2017 due to a significant decline in the total return index.
Chemed Corporation (CHE) was downgraded to C from C+ on 8/23/2017 due to a significant decline in the total return index.
C
Hold
8/2/2017Downgrade
Chemed Corporation (CHE) was downgraded to C+ from B on 8/2/2017 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $1.78 to -$1.3527, operating cash flow declined 54.15% from $68.79M to $31.54M, and the quick ratio declined from 0.95 to 0.49.
Chemed Corporation (CHE) was downgraded to C+ from B on 8/2/2017 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from $1.78 to -$1.3527, operating cash flow declined 54.15% from $68.79M to $31.54M, and the quick ratio declined from 0.95 to 0.49.
B
Buy
5/16/2017Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 5/16/2017 due to a large decline in the total return index, volatility index and valuation index.
Chemed Corporation (CHE) was downgraded to B from B+ on 5/16/2017 due to a large decline in the total return index, volatility index and valuation index.
B
Buy
5/1/2017Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 5/1/2017 due to a significant increase in the growth index, total return index and valuation index. Operating cash flow increased 877.07% from $7.04M to $68.79M, and total revenue increased 0.59% from $403.48M to $405.86M.
Chemed Corporation (CHE) was upgraded to B+ from B on 5/1/2017 due to a significant increase in the growth index, total return index and valuation index. Operating cash flow increased 877.07% from $7.04M to $68.79M, and total revenue increased 0.59% from $403.48M to $405.86M.
B
Buy
3/31/2017Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 3/31/2017 due to a decline in the total return index and valuation index.
Chemed Corporation (CHE) was downgraded to B from B+ on 3/31/2017 due to a decline in the total return index and valuation index.
B
Buy
3/16/2017Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 3/16/2017 due to a noticeable increase in the total return index and volatility index.
Chemed Corporation (CHE) was upgraded to B+ from B on 3/16/2017 due to a noticeable increase in the total return index and volatility index.
B
Buy
2/27/2017Downgrade
Chemed Corporation (CHE) was downgraded to B from B+ on 2/27/2017 due to a substantial decline in the growth index, valuation index and dividend index. Operating cash flow declined 87.18% from $54.91M to $7.04M.
Chemed Corporation (CHE) was downgraded to B from B+ on 2/27/2017 due to a substantial decline in the growth index, valuation index and dividend index. Operating cash flow declined 87.18% from $54.91M to $7.04M.
B
Buy
1/10/2017Upgraded
Chemed Corporation (CHE) was upgraded to B+ from B on 1/10/2017 due to a large increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.32 to 0.23.
Chemed Corporation (CHE) was upgraded to B+ from B on 1/10/2017 due to a large increase in the volatility index, total return index and solvency index. Debt to equity declined from 0.32 to 0.23.
B
Buy
7/21/2016Upgraded
Chemed Corp. (CHE) was upgraded to B from B- on 7/21/2016 due to a noticeable increase in the total return index.
Chemed Corp. (CHE) was upgraded to B from B- on 7/21/2016 due to a noticeable increase in the total return index.
B
Buy
5/4/2016Downgrade
Chemed Corp. (CHE) was downgraded to B- from B on 5/4/2016 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 87.64% from $58.42M to $7.22M, debt to equity increased from 0.18 to 0.3, and earnings per share declined from $1.7235 to $1.45.
Chemed Corp. (CHE) was downgraded to B- from B on 5/4/2016 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 87.64% from $58.42M to $7.22M, debt to equity increased from 0.18 to 0.3, and earnings per share declined from $1.7235 to $1.45.
B
Buy
3/11/2016Downgrade
Chemed Corp. (CHE) was downgraded to B from A- on 3/11/2016 due to a substantial decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.87 to 0.71.
Chemed Corp. (CHE) was downgraded to B from A- on 3/11/2016 due to a substantial decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.87 to 0.71.
A
Buy
1/13/2016Downgrade
Chemed Corp. (CHE) was downgraded to A- from A on 1/13/2016 due to a noticeable decline in the total return index.
Chemed Corp. (CHE) was downgraded to A- from A on 1/13/2016 due to a noticeable decline in the total return index.
A
Buy
11/18/2015Downgrade
Chemed Corp. (CHE) was downgraded to A from A+ on 11/18/2015 due to a decline in the volatility index, total return index and valuation index.
Chemed Corp. (CHE) was downgraded to A from A+ on 11/18/2015 due to a decline in the volatility index, total return index and valuation index.
A
Buy
11/3/2015Upgraded
Chemed Corp. (CHE) was upgraded to A+ from A on 11/3/2015 due to an increase in the total return index, growth index and solvency index. Debt to equity declined from 0.33 to 0.28, EBIT increased 14.98% from $44.6M to $51.28M, and earnings per share increased from $1.55 to $1.65.
Chemed Corp. (CHE) was upgraded to A+ from A on 11/3/2015 due to an increase in the total return index, growth index and solvency index. Debt to equity declined from 0.33 to 0.28, EBIT increased 14.98% from $44.6M to $51.28M, and earnings per share increased from $1.55 to $1.65.
A
Buy
10/29/2015Upgraded
Chemed Corp. (CHE) was upgraded to A from A- on 10/29/2015 due to an increase in the volatility index and total return index.
Chemed Corp. (CHE) was upgraded to A from A- on 10/29/2015 due to an increase in the volatility index and total return index.
A
Buy
9/29/2015Downgrade
Chemed Corp. (CHE) was downgraded to A- from A on 9/29/2015 due to a noticeable decline in the total return index and volatility index.
Chemed Corp. (CHE) was downgraded to A- from A on 9/29/2015 due to a noticeable decline in the total return index and volatility index.
A
Buy
7/31/2015Upgraded
Chemed Corp. (CHE) was upgraded to A from A- on 7/31/2015 due to a substantial increase in the total return index, growth index and solvency index. Operating cash flow increased 362.78% from $12.37M to $57.26M, earnings per share increased from $1.4 to $1.55, and EBIT increased 9.93% from $40.57M to $44.6M.
Chemed Corp. (CHE) was upgraded to A from A- on 7/31/2015 due to a substantial increase in the total return index, growth index and solvency index. Operating cash flow increased 362.78% from $12.37M to $57.26M, earnings per share increased from $1.4 to $1.55, and EBIT increased 9.93% from $40.57M to $44.6M.
A
Buy
2/27/2015Upgraded
Chemed Corp. (CHE) was upgraded to A- from B+ on 2/27/2015 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 905.26% from $5.9M to $59.27M, EBIT increased 24.37% from $40.66M to $50.57M, and earnings per share increased from $1.39 to $1.7077.
Chemed Corp. (CHE) was upgraded to A- from B+ on 2/27/2015 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 905.26% from $5.9M to $59.27M, EBIT increased 24.37% from $40.66M to $50.57M, and earnings per share increased from $1.39 to $1.7077.
B
Buy
11/25/2014Upgraded
Chemed Corp. (CHE) was upgraded to B+ from B on 11/25/2014 due to a major increase in the total return index and volatility index.
Chemed Corp. (CHE) was upgraded to B+ from B on 11/25/2014 due to a major increase in the total return index and volatility index.
B
Buy
11/10/2014Downgrade
Chemed Corp. (CHE) was downgraded to B from B+ on 11/10/2014 due to a decline in the volatility index and valuation index.
Chemed Corp. (CHE) was downgraded to B from B+ on 11/10/2014 due to a decline in the volatility index and valuation index.
B
Buy
11/7/2014Downgrade
Chemed Corp. (CHE) was downgraded to B+ from A- on 11/7/2014 due to a significant decline in the growth index, volatility index and total return index. Operating cash flow declined 89.65% from $56.96M to $5.9M, EBIT declined 3.15% from $41.52M to $40.21M, and total revenue declined 0.5% from $360.18M to $358.39M.
Chemed Corp. (CHE) was downgraded to B+ from A- on 11/7/2014 due to a significant decline in the growth index, volatility index and total return index. Operating cash flow declined 89.65% from $56.96M to $5.9M, EBIT declined 3.15% from $41.52M to $40.21M, and total revenue declined 0.5% from $360.18M to $358.39M.
A
Buy
8/1/2014Upgraded
Chemed Corp. (CHE) was upgraded to A- from B+ on 8/1/2014 due to a major increase in the growth index, solvency index and total return index. The quick ratio increased from 0.46 to 0.77, earnings per share increased from $1.12 to $1.36, and debt to equity declined from 0.42 to 0.36.
Chemed Corp. (CHE) was upgraded to A- from B+ on 8/1/2014 due to a major increase in the growth index, solvency index and total return index. The quick ratio increased from 0.46 to 0.77, earnings per share increased from $1.12 to $1.36, and debt to equity declined from 0.42 to 0.36.
B
Buy
5/5/2014Downgrade
Chemed Corp. (CHE) was downgraded to B+ from A- on 5/5/2014 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 179.03% from $14.99M to -$11.85M, earnings per share declined from $1.2801 to $1.12, and EBIT declined 7.07% from $39.44M to $36.65M.
Chemed Corp. (CHE) was downgraded to B+ from A- on 5/5/2014 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 179.03% from $14.99M to -$11.85M, earnings per share declined from $1.2801 to $1.12, and EBIT declined 7.07% from $39.44M to $36.65M.
NYSE
05/20/2024 4:00PM Eastern
Quotes delayed
